18th Annual BIO CEO & Investor Conference :: February 8-9, 2016 :: New York City :: Company Presentations
Key: = New IPO Since 1/1/2015 = Buzz of BIO Winner = Patient Advocacy Group = Buzz of BIO Finalist #BIOCEO16 Phase of Development: = Discovery = Pre-Clinical = Phase I = Phase II = Phase III = NDA/In-Review = Multiple Products in Market = Not Applicable/Other Monday, February 8th Duke of Windsor Park South Park North Conrad Louis XVI 8:00 AM Altimmune, Inc. NovaBay Pharmaceuticals, Inc. (NYSE MKT: NBY) Capnia, Inc. (NASDAQ: CAPN) Galmed Pharmaceuticals (NASDAQ: GLMD) Cipher Pharmaceuticals (NASDAQ: CPHR) Infectious Diseases 8:15 AM Ophthamology Diagnostics Ziarco Group Ltd Gastrointestinal Dermatology Inflammation 8:30 AM IMCYSE SA Alcobra (NASDAQ: ADHD) Protea Biosciences Group, Inc. (OTCQB: PRGB) Synthetic Biologics, Inc. (NYSE MKT: SYN) Pluristem Therapeutics Inc. (NASDAQ: PSTI) Platform for Therapeutics 8:45 AM CNS/Neurological Tools/Drug Development Support Technology Aridis Pharmaceuticals Inc. Other Cardiovascular Infectious Diseases 9:00 AM Mariposa Health Inc Tonix Pharmaceuticals Holdings, Inc. (NASDAQ: TNXP) Aimmune Therapeutics (NASDAQ: AIMT) Palatin Technologies, Inc. (NYSE MKT: PTN) Resverlogix Corp. (TSX: RVX) Respiratory 9:15 AM CNS/Neurological Inflammation The Michael J Fox Foundation for Parkinson's Research Reproductive/Sexual Health Cardiovascular CNS/Neurological 9:30 AM ArmaGen, Inc. Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) Axsome Therapeutics (NASDAQ: AXSM) Apricus Biosciences, Inc. (NASDAQ: APRI) Capricor (NASDAQ: CAPR) CNS/Neurological 9:45 AM Oncology CNS/Neurological Azevan Pharmaceuticals, Inc. Reproductive/Sexual Health Cardiovascular CNS/Neurological 10:00 AM Hereditary Neuropathy Foundation DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Prothena Corporation plc (NASDAQ: PRTA) RespireRx (OTC: RSRX) CNS/Neurological 10:15 AM Oncology Oncology AgeneBio, Inc. Multiple Therapeutics Respiratory CNS/Neurological 10:30 AM HIGHLAND THERAPEUTICS INC. OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED) Cyclacel Pharmaceuticals, Inc.(NASDAQ: CYCC) Galectin Therapeutics Inc (NASDAQ: GALT) Aradigm Corporation (NASDAQ: ARDM) CNS/Neurological 10:45 AM Oncology Oncology Accera Inc Multiple Therapeutics Respiratory CNS/Neurological 11:00 AM RaNA Therapeutics, Inc OncoSec Medical Incorporated (NASDAQ: ONCS) CytRx Corporation (NASDAQ: CYTR) BioSpecifics Technologies Corp. (NASDAQ: BSTC) Opexa Therapeutics (NASDAQ: OPXA) Platform for Therapeutics 11:15 AM Oncology Oncology Aurora BioPharma, Inc. Other Immunology Immunology 11:30 AM KPI Therapeutics Oxigene, Inc. (NASDAQ: OXGN) Galena Biopharma Inc. (NASDAQ: GALE) Akebia Therapeutics (NASDAQ: AKBA) Neovacs (EPA: ALNEV) Immunology 11:45 AM Oncology Oncology Targazyme, Inc. Multiple Therapeutics Immunology Immunology 12:00 PM - 1:255 Lunch PM 1:00 PM NeuroRx, Inc. TG Therapeutics, Inc. (NASDAQ: TGTX) Oramed Pharmaceuticals (NASDAQ: ORMP) Inotek Pharmaceuticals (NASDAQ: ITEK) Oryzon Genomics (Madrid Exchange: ORY) CNS/Neurological 1:15 PM Oncology Drug Delivery JDRF International Ophthamology Oncology Multiple Therapeutics 1:30 PM Sutro Biopharma Celator Pharmaceuticals, Inc (NASDAQ: CPXX) Bionik Laboratories (OTCQX: BNKL) Cytokinetics, Inc (NASDAQ: CYTK) Cerulean Pharma Inc. (NASDAQ: CERU) Oncology 1:45 PM Oncology CNS/Neurological Atreca, Inc. Orphan/Rare Diseases Oncology Oncology 2:00 PM Batavia N.V. ImmunoCellular Therapeutics, Ltd (NYSE MKT: IMUC) Bionomics Ltd (ASX: BNO, OTCQX: BNOEF) Mast Therapeutics, Inc. (NYSE MKT: MSTX) Athersys, Inc. (NASDAQ: ATHX) Tools/Drug Development Support Technology 2:15 PM Oncology CNS/Neurological Progenra Inc Orphan/Rare Diseases Regenerative Medicine Oncology 2:30 PM OticPharma, Ltd. Delcath Systems, Inc. (NASDAQ: DCTH) StemCells, Inc. (NASDAQ: STEM) Horizon Pharma plc (NASDAQ: HZNP) BioLineRx (NASDAQ: BLRX, TASE: BLRX) Other 2:45 PM Oncology CNS/Neurological GrayBug, Inc Orphan/Rare Diseases Oncology Ophthamology 3:00 PM Ocugen, Inc. Provectus Biopharmaceuticals, Inc (NYSE MKT: PVCT) Cerecor Inc. (NASDAQ: CERC) GlycoMimetics (NASDAQ: GLYC) NephroGenex, Inc. (NASDAQ: NRX) Ophthamology 3:15 PM Oncology CNS/Neurological Tyrogenex, Inc. Orphan/Rare Diseases Metabolic Diseases Ophthamology 3:30 PM Milestone Pharmaceuticals Inc. Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) Probiodrug AG (Euronext Amsterdam: PBD) La Jolla Pharmaceutical Company (NASDAQ: LJPC) Relmada Therapeutics (OTCQB: RLMD) Cardiovascular 3:45 PM Oncology CNS/Neurological The Leukemia & Lymphoma Society Orphan/Rare Diseases Pain Management Oncology 4:00 PM Viramal Limited Abeona Therapeutics, Inc (NASDAQ: ABEO) Onconova Therapeutics, Inc. (NASDAQ: ONTX) CytoSorbents Corporation (NASDAQ: CTSO) DURECT Corporation (NASDAQ: DRRX) Reproductive/Sexual Health 4:15 PM Gene/Cell Therapy Oncology Millendo Therapeutics Inc. Medical Devices Pain Management Orphan/Rare Diseases 4:30 PM Albireo Ltd. Rexahn Pharmaceuticals (NYSE MKT: RNN) MEI Pharma, Inc. (NASDAQ: MEIP) Trevena Inc (NASDAQ: TRVN) PuriCore (LSE: PURI.L) Orphan/Rare Diseases 4:45 PM Oncology Oncology Opsona Therapeutics Ltd Multiple Therapeutics Inflammation Orphan/Rare Diseases 5:00 PM Bio-Path Holdings, Inc. (NASDAQ: BPTH) BioLife Solutions, Inc. (NASDAQ: BLFS) Addex Therapeutics Ltd (SWX: ADXN) Genocea Biosciences Inc (NASDAQ: GNCA) Proteon Therapeutics, Inc. (NASDAQ: PRTO) 5:15 PM Oncology Tools/Drug Development Support Technology CNS/Neurological Immunology Cardiovascular
5:30 PM NanoViricides, Incorporated (NYSE: NNVC) Curis, Inc. (NASDAQ: CRIS) Viking Therapeutics, Inc. (NASDAQ: VKTX) Immune Pharmaceuticals (NASDAQ: IMNP) Can-Fite BioPharma, Ltd. (NYSE MKT: CANF) 5:45 PM Infectious Diseases Oncology Metabolic Diseases Immunology Inflammation
Accurate as of 1/28/2016 18th Annual BIO CEO & Investor Conference :: February 8-9, 2016 :: New York City :: Company Presentations
Key: = New IPO Since 1/1/2015 = Buzz of BIO Winner = Patient Advocacy Group = Buzz of BIO Finalist #BIOCEO16 Phase of Development: = Discovery = Pre-Clinical = Phase I = Phase II = Phase III = NDA/In-Review = Multiple Products in Market = Not Applicable/Other Tuesday, February 9th Duke of Windsor Park South Park North Conrad Louis XVI 8:00 AM ERYTECH Pharma (EPA: ERYP) Verastem, Inc. (NASDAQ: VSTM) Biocept, Inc. (NASDAQ: BIOC) Catalyst Biosciences, Inc. (NASDAQ: CBIO) Neos Therapeutics (NASDAQGM: NEOS) 8:15 AM Oncology Oncology Diagnostics Orphan/Rare Diseases Drug Delivery
8:30 AM SciClone Pharmaceuticals Inc (NASDAQ: SCLN) Argos Therapeutics, Inc. (NASDAQ: ARGS) OncoCyte (NYSE: OCX) Corbus Pharmaceuticals (NASDAQ: CRBP) SteadyMed Therapeutics (NASDAQ: STDY) 8:45 AM Oncology Oncology Diagnostics Orphan/Rare Diseases Drug Delivery
9:00 AM ProteoThera, Inc. Adaptimmune Therapeutics plc (NASDAQ: ADPT) AVEO Oncology (NASDAQ: AVEO) Newron Pharmaceuticals SpA (SWX: NWRN) ContraFect Corporation (NASDAQ: CFRX) Inflammation 9:15 AM Oncology Oncology Nimbus Therapeutics LLC Orphan/Rare Diseases Infectious Diseases Metabolic Diseases 9:30 AM Izun Pharmaceuticals Selvita S.A. (WSE: SLV) Visiomed Group SA (Alternext: ALVMG) Catalyst Pharmaceuticals (NASDAQ: CPRX) Dipexium Pharmaceuticals, Inc. (NASDAQ: DPRX) Multiple Therapeutics 9:45 AM Oncology Medical Devices KineMed, Inc Orphan/Rare Diseases Infectious Diseases Multiple Therapeutics 10:00 AM Synlogic Biothera Pharmaceuticals Inc. Sophiris (NASDAQ: SPHS) Ocera Therapeutics, Inc (NASDAQ: OCRX) Nicox (EPA: COX) Metabolic Diseases 10:15 AM Oncology Oncology Rebiotix Inc Orphan/Rare Diseases Ophthamology Gastrointestinal 10:30 AM Bigfoot Biomedical MabVax Therapeutics Holdings, Inc. (OTCQB: MBVX) Oncolytics Biotech (OTCQX: ONCYF, TSX: ONC) ProMetic Life Sciences (TSX: PLI, OTCQX: PFSCF) Nemus Bioscience, Inc. (OTCQB: NMUS) Digital Health 10:45 AM Oncology Oncology Mitotech S.A. Orphan/Rare Diseases Ophthamology Ophthamology 11:00 AM Provista Diagnostics, Inc Mirna Therapeutics Inc. (NASDAQ: MIRN) CEL-SCI Corporation (NYSE MKT: CVM) Summit Therapeutics (NASDAQ: SMMT) pSivida Corp. (NASDAQ: PSDV) Diagnostics 11:15 AM Oncology Oncology Phagelux, Inc. Orphan/Rare Diseases Ophthamology Platform for Therapeutics 11:30 AM Cooperative Human Tissue Network (CHTN) Caladrius Biosciences, Inc. (NASDAQ: CLBS) Vascular Biogenics (NASDAQ: VBLT) BioBlast Pharma Ltd. (NASDAQ: ORPN) ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV) Other 11:45 AM Other Oncology Symic Biomedical, Inc. Orphan/Rare Diseases Ophthamology Multiline Global Biopharma 12:00 PM - 12:55 Plenary Lunch in Astor / Fireside Chat with Christi Shaw, US Head, President, Novartis Corporation PM
1:00 PM EnGeneIC Ltd. ZIOPHARM Oncology, Inc. (NASDAQ: ZIOP) Relypsa, Inc. (NASDAQ: RLYP) AcelRx Pharmaceuticals (NASDAQ: ACRX) VBI Vaccines Inc. (NASDAQ: VBIV) Oncology 1:15 PM Oncology Metabolic Diseases Xcovery, Holding Company CNS/Neurological Immunology Oncology 1:30 PM G1 Therapeutics Inc. Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) CymaBay Therapeutics, Inc. (NASDAQ: CBAY) Anavex Life Sciences Corp. (NASDAQ: AVXL) Oasmia Pharmaceutical AB (NASDAQ: OASM, FWB: OMAX.GR) Oncology 1:45 PM Oncology Metabolic Diseases Helomics Corporation CNS/Neurological Oncology Oncology 2:00 PM BeyondSpring Pharmaceuticals, Inc. Diffusion Pharmaceuticals Inc. (OTCQX: DFFN) BioTime (NYSE: BTX) vTv Therapeutics (NASDAQ: VTVT) Aurinia Pharmaceuticals Inc (NASDAQ: AUPH, TSX: AUP) Oncology 2:15 PM Oncology Regenerative Medicine New York Stem Cell Foundation CNS/Neurological Immunology Platform for Therapeutics 2:30 PM Bell Biosystems, Inc. Calithera Biosciences (NASDAQ: CALA) Zafgen (NASDAQ: ZFGN) CoLucid Pharmaceuticals, Inc. (NASDAQ: CLCD) RXi Pharmaceuticals Corporation (NASDAQ: RXII) Regenerative Medicine 2:45 PM Other Metabolic Diseases NovaHep AB CNS/Neurological Dermatology Regenerative Medicine 3:00 PM Nanobiotix (Euronext: NANO) Orexigen Therapeutics, Inc. (NASDAQ: OREX) Conatus Pharmaceuticals Inc. (NASDAQGM: CNAT) Alkermes (NASDAQ: ALKS) Alnylam Pharmaceuticals (NASDAQ: ALNY) 3:15 PM Oncology Metabolic Diseases Gastrointestinal CNS/Neurological Orphan/Rare Diseases
3:30 PM OncBioMune Pharmaceuticals INC (OTCQB: OBMP) Histogenics Corporation (NASDAQ: HSGX) Tobira Therapeutics, Inc (NASDAQ: TBRA) PAION Inc. (FSE: PA8) Aethlon Medical, Inc. (NASDAQ: AEMD) 3:45 PM Oncology Regenerative Medicine Gastrointestinal Other Medical Devices
4:00 PM Imugene Ltd (ASX: IMU) Asterias (NYSE: AST) RedHill Biopharma Ltd (NASDAQ: RDHL, TASE: RDHL) PDL BioPharma, Inc. (NASDAQ: PDLI) Stemline Therapeutics (NASDAQ: STML) 4:15 PM Oncology Regenerative Medicine Gastrointestinal Other Oncology
Accurate as of 1/28/2016